Early Changes in Patient-Relevant Endpoints in Three Tralokinumab Pivotal Phase 3 Trials (ECZTRA 1−3) in Adult Patients with Moderate-to-Severe Atopic Dermatitis. J of Skin [Internet]. 2020 Oct. 27 [cited 2025 Apr. 19];4(6):s98. Available from: https://skin.dermsquared.com/skin/article/view/1068